Description |
bone gamma-carboxyglutamate protein |
cathepsin S |
Image |
No pdb structure |
|
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
- Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide
- Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide
- Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide
- N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE
- N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE
- N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE
- N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE
- N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE
- (1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE
- 2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL
- N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide
- N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide
- Fostamatinib
|
Diseases |
|
|
GWAS |
- Estimated glomerular filtration rate ( 30604766)
- Mean corpuscular hemoglobin concentration ( 20139978)
- Mosaic loss of chromosome Y (Y chromosome dosage) ( 31624269)
- White matter hyperintensity burden ( 25663218)
|
|
Interacting Genes |
6 interacting genes:
ASPH
CTSB
CTSD
CTSH
CTSS
GGCX
|
9 interacting genes:
ANXA2
BGLAP
CST3
CST5
KNG1
PLCG1
SERPINB3
SERPINB4
SLPI
|
Entrez ID |
632 |
1520 |
HPRD ID |
00205 |
00292 |
Ensembl ID |
ENSG00000242252
|
ENSG00000163131
|
Uniprot IDs |
P02818
|
P25774
|
PDB IDs |
|
1BXF
1GLO
1MS6
1NPZ
1NQC
2C0Y
2F1G
2FQ9
2FRA
2FRQ
2FT2
2FUD
2FYE
2G6D
2G7Y
2H7J
2HH5
2HHN
2HXZ
2OP3
2R9M
2R9N
2R9O
3IEJ
3N3G
3N4C
3OVX
4P6E
4P6G
5QBU
5QBV
5QBW
5QBX
5QBY
5QBZ
5QC0
5QC1
5QC2
5QC3
5QC4
5QC5
5QC6
5QC7
5QC8
5QC9
5QCA
5QCB
5QCC
5QCD
5QCE
5QCF
5QCG
5QCH
5QCI
5QCJ
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|